UroGen Pharma Ltd. (URGN)
28.89
-0.99
(-3.31%)
USD |
NASDAQ |
May 22, 16:00
28.87
-0.02
(-0.07%)
After-Hours: 20:00
UroGen Pharma EPS Diluted (Quarterly) : -0.4698 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.60 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| United Therapeutics Corp. | 5.824 |
| Puma Biotechnology, Inc. | -0.0738 |
| TG Therapeutics, Inc. | 0.1236 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.57M |
| Revenue (Quarterly) | 50.96M |
| Total Expenses (Quarterly) | 74.53M |
| Enterprise Value | 1.463B |
| Gross Profit Margin (Quarterly) | 91.88% |
| Profit Margin (Quarterly) | -46.26% |
| Earnings Yield | -9.54% |
| Normalized Earnings Yield | -9.536 |